Shivali is an Associate Scientist II on the Discovery Research team at Gentibio, where she helps develop alternative strategies to restore Treg-mediated immune tolerance. Shivali received her BA in Biology and Computer Science from Columbia University in 2022. During her undergrad, she had the opportunity to work under Dr. Donna L. Farber, where she studied the development and tissue localization of T cell-driven immune responses in early life. As an advocate of accessibility and inclusion in science, Shivali also led Columbia’s Undergraduate Science Journal (CUSJ) as their Director of Outreach and continues on as a mentor for the group.
Current role
Associate Scientist II at Atalanta Therapeutics
Research Associate Scientist II at DJS Antibodies
Associate Scientist Ii, Upstream Process Development at Frontera Therapeutics
Associate Scientist II, Nanoparticle Process Development at Strand Therapeutics
Associate Scientist II at GentiBio
Access the worlds's biggest network of public org charts
Learn more